What's in Revolution Medicines, Inc.'s pipeline?

Revolution Medicines, Inc. has 11 drugs in our index: 1 marketed, 0 filed, 3 in Phase 3, 1 in Phase 2, 6 in Phase 1.

Which companies overlap with Revolution Medicines, Inc.'s portfolio?

Top competitors by shared drug class: Alliance for Clinical Trials in Oncology, Amgen, Asan Medical Center, AstraZeneca, Beijing Friendship Hospital.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/revolution-medicines-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Revolution Medicines, Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Revolution Medicines, Inc. pipeline: 1 marketed, 0 filed, 3 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 3 Phase 3 1 Phase 2 6 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
mFOLFOX6 regimen	mFOLFOX6 regimen	marketed
daraxonrasib	daraxonrasib	phase 3			Other
mFOLFIRINOX regimen	mFOLFIRINOX regimen	phase 3	Combination chemotherapy regimen		Oncology
RMC-6236	RMC-6236	phase 3	KRAS G12C inhibitor	KRAS G12C	Oncology

Therapeutic area mix

Other · 3
Oncology · 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Alliance for Clinical Trials in Oncology · 1 shared drug class
Amgen · 1 shared drug class
Asan Medical Center · 1 shared drug class
AstraZeneca · 1 shared drug class
Beijing Friendship Hospital · 1 shared drug class
Centre Hospitalier Universitaire Dijon · 1 shared drug class
Centre Hospitalier Universitaire de Besancon · 1 shared drug class
Affiliated Cancer Hospital & Institute of Guangzhou Medical University · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Revolution Medicines, Inc.:

Cite this brief

Drug Landscape (2026). Revolution Medicines, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/revolution-medicines-inc. Accessed 2026-05-16.